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Abstract
Background: Previous research has provided evidence that socioeconomic status has an impact
on invasive treatments use after acute myocardial infarction. In this paper, we compare the
socioeconomic inequality in the use of high-technology diagnosis and treatment after acute
myocardial infarction between the US, Quebec and Belgium paying special attention to financial
incentives and regulations as explanatory factors.
Methods: We examined hospital-discharge abstracts for all patients older than 65 who were
admitted to hospitals during the 1993–1998 period in the US, Quebec and Belgium with a primary
diagnosis of acute myocardial infarction. Patients' income data were imputed from the median
incomes of their residential area. For each country, we compared the risk-adjusted probability of
undergoing each procedure between socioeconomic categories measured by the patient's area
median income.
Results: Our findings indicate that income-related inequality exists in the use of high-technology
treatment and diagnosis techniques that is not justified by differences in patients' health
characteristics. Those inequalities are largely explained, in the US and Quebec, by inequalities in
distances to hospitals with on-site cardiac facilities. However, in both Belgium and the US,
inequalities persist among patients admitted to hospitals with on-site cardiac facilities, rejecting the
hospital location effect as the single explanation for inequalities. Meanwhile, inequality levels diverge
across countries (higher in the US and in Belgium, extremely low in Quebec).
Conclusion: The findings support the hypothesis that income-related inequality in treatment for
AMI exists and is likely to be affected by a country's system of health care.
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Background
Previous research has provided evidence that socioeco-
nomic status (SES) has an impact on invasive treatments
use for acute myocardial infarction [1-7]. The causes for
such inequalities remain difficult to discern. Some have
argued that underprivileged patients could be more reluc-
tant to undergo invasive procedures [6]; other evidence
suggests that physicians perceive higher severity and
greater post-intervention risk for low-income patients [4];
some explain disparities as the result of unfounded physi-
cians' prejudices against specific groups such as women
and black patients [8]; finally, over-provision to the bet-
ter-off has also been mentioned, as a significant propor-
tion of referrals from general practitioners to specialists
are made upon patients' requests [9,10].
Focus has essentially been directed at physicians' and
patients' beliefs and attitudes. Nevertheless, physicians
and patients act in the framework of health care systems,
whose influence on physicians' and patients' behaviors,
through regulations and incentives, has been well docu-
mented in the area of cardio-vascular treatments.
Recently, research has emphasized the importance of
health care systems on the adoption and diffusion of
high-technology treatments for cardio-vascular disease
[11,12]. A recent contribution suggests that universal cov-
erage explains most of the very low inequality in access to
invasive procedures in Canada [13].
The health care organization is likely to influence not only
how care is provided, but also to whom it is provided. In
this study, we compare health inequality in the use of
diagnosis (cardiac catheterization, CATH) and treatment
(coronary artery bypass graft, CABG, and percutaneous
coronary intervention, PCI) for acute myocardial infarc-
tion (AMI) between three very different health care financ-
ing systems: the US (Medicare), Quebec and Belgium.
This cross-country comparison aims to elucidate how
health care systems may also be a determinant of inequal-
ities in treatment.
Methods
Sample
Our sample includes all patients admitted to a hospital
with a diagnosis of acute myocardial infarction (AMI,
code 410 of the International Classification of Diseases,
9threvision, Clinical Modification: ICD-9-CM).
We follow the exclusion criteria used in other studies
[5,11,14]. We exclude patients discharged alive after a stay
of less than three days, those transferred from another
acute care facility to avoid double counting and those hos-
pitalized with an AMI in the year before the index admis-
sion and patients older than 99 in order to limit variations
in severity.
Our sample is restricted to all patients 65 and older hos-
pitalized from 1993–1998. US data includes all Medicare
AMI patients (1,614,922 discharges), data from Quebec
and Belgium includes all AMI patients aged 65 and older
(37,190 in Quebec, 49,445 in Belgium).
Modeling diagnosis and treatment for AMI
We assume that the hospital's clinical team, when decid-
ing treatment for AMI, is confronted with four independ-
ent alternatives. The first option is to perform neither a
CATH nor any invasive treatment. The second option is
for a physician to perform a CATH, but not to follow it
with any invasive procedure. The third option is to per-
form a PCI following the CATH. The final alternative is to
perform a CABG after performing either a PCI or a CATH
or both.
We construct a treatment variable as a categorical depend-
ent variable whose categories are these four alternatives.
We model the probability that the patient will fall into
any of those categories, using a multinomial logit model.
Coefficients from multinomial logit models are difficult
to interpret and potentially misleading; to overcome this
difficulty, we compute the adjusted probabilities associ-
ated with each outcome holding constant all other charac-
teristics. SAS (version 8.2) statistical package was used.
Explanatory variables
Table 1 displays the explanatory variables included in the
regressions, with their definitions. These variables are
commonly used when modeling treatment choice for AMI
[14]. Year dummies are included to control for technolog-
ical diffusion, which may be correlated with income dis-
tribution.
We use the distance to the closest hospital with on-site
cardiac facilities as the explanatory variable, given its
known influence on the use of cardiac services [15]. We
use straight-line distances between the patient's area geo-
graphical center and the nearest equipped hospital's area
geographical center. The use of a straight-line instead of
aerial distances is quite common in the literature, as stud-
ies generally assume that both measures are correlated
[15,16]. Using the distance to the closest equipped hospi-
tal instead of the distance to the actual hospital used for
care avoids a confounding effect; indeed, the hospital
choice often determines the treatment received [17].
We use the median income of the patient's residential area
in order to determine the socioeconomic status, as a typi-
cal approach [2,5]. Median incomes are not comparable
across countries because of different purchasing power
and definition. US area-based information is issued from
the 1990 census. The median income is based on the tax-
able household income, including many sources of reve-BMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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nue (wages and salary, social benefits, dividends, etc.).
Area-based income data for Quebec are issued from the
Profile of Forward Sortation Areas, obtained from the
1996 Canada Census data. Median income corresponds
to the median personal net income and also includes
many other sources of revenue. For Belgium, area-based
data are issued from the annual fiscal register (1995 data
used for this study). Median income corresponds to the
median taxable income by declaration and includes all
taxable revenue. None of the countries standardize
median income by the household size. Instead of using
the median income itself, we distribute areas in quintiles
according to their median income, providing a compara-
ble relative measure of SES.
Adjusted probabilities of each intervention are calculated
for each income quintile, controlling for age and comor-
bidities. Using 95% confidence intervals, we observe
whether adjusted probabilities significantly differ across
income quintiles. We assume that patient's median
income and intervention are significantly associated
whenever adjusted probabilities significantly differ
between at least two income quintiles.
Adjusting for distances and existence of on-site facilities
The First model does not include distances, while the Sec-
ond model does. These separate models allow for measur-
ing the importance of distances in explaining inequalities
in use. In a Third model, we check whether inequality exists
among patients admitted at hospitals with on-site cardiac
facilities (for catheterization and revascularization).
Indeed, socio-economic status may still lead to treatment
disparities when the distance factor and the hospital
choice are neutralized. Therefore, we use the sub-sample
of those patients admitted at hospitals with on-site facili-
ties, including 782,715 discharges in the US, 5,859 in
Quebec and 14,952 in Belgium.
Results
Patients' characteristics are displayed in Table 2. In all
three countries, we observe relatively higher rates of use of
cardiac procedures among patients who come from the
highest-income areas. However, no income gradient is
present as rates are higher in the lowest-income areas
compared with the middle-income ones. Area median
income and distances to hospitals with on-site cardiac
facilities follow similar patterns. In the US, patients from
the poorest areas live on average 45 km away from the
closest hospital with on-site cardiac facilities, but patients
Table 1: Explanatory variables used in the multivariate analysis
VARIABLE DEFINITION
Patient-related clinical indicators
FEMALE Dummy variable taking the value '1' for female patients
AGEGRP0-AGEGRP5 One dummy variable for each age group 
(where AGEGRP0 includes patients aged 65–69 and AGEGRP5 patients older than 90)
YR93-YR98 One dummy variable for each year
DIST_CATH Distance from the patient's area geographical center to the area geographical center of the nearest hospital 
offering cardiac CATH.
DIST_CARD Distance from the patient's area geographical center to the area geographical center of the nearest hospital 
offering CABG or PCI.
COCHF Congestive heart failure
CARD Cardiac dysrhythmias
PULED Pulmonary edema
SHOCK Shock
CRF Chronic renal failure
ARF Acute renal failure
DIABET Diabetes
MAL Malignancy
CERVAS Cerebrovascular disease
Area-based socioeconomic indicators
INC Median family income in ZIP code area of residence.
INC_Q1 The patient's area belongs to the lowest median income quintile in country X
INC_Q2 The patient's area belongs to the 2nd median income quintile in country X
INC_Q3 The patient's area belongs to the 3rd median income quintile in country X
INC_Q4 The patient's area belongs to the 4th median income quintile in country X
INC_Q5 The patient's area belongs to the highest median income quintile in country XBMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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from the richest areas live on average only 13 km away. In
Quebec and Belgium, we observe an inverse U-shaped
curve when comparing SES and distance from a cardiac
facility. Note also that the poorest areas, situated farther
from equipped facilities, are also the less populated in the
US. It seems thus that, contrary to Quebec and Belgium,
income and population density (a proxy of urbanization)
are correlated in the US.
Adjusted probabilities appear in Table 3. The value
denoted 'range' gives the percentage difference between
the categories exhibiting the lowest and the highest
adjusted probability. We present the findings by country.
United States
Procedure use in all hospitals, unadjusted for distance (Model 1)
In the US, patients from highest-income areas have a sig-
nificantly higher adjusted rate of procedures followed by
patients living in Q4-areas. Patients from lowest-income
areas (Quintile 1, referred to as Q1) exhibit higher rates
than patients in Q2-areas for CATH, than Q2- and Q3-
areas for PCI and CABG. Patients from the poorest areas
have a 68.2%-adjusted probability of not receiving any
treatment, compared with a 65.1%-adjusted probability
among patients from richest areas.
Procedure use in all hospitals, adjusted for distance (Model 2)
Results change dramatically when distance is taken into
account. Adjusted probabilities significantly increase for
patients from the poorest areas (from 13.7 to 15.6% for
CATH). Consequently, even though differences among
groups are still significant, they become rather weak in
magnitude. The discrepancy between the lowest and the
highest adjusted rate decreases from 13.99 to 1.72% for
CATH, 13.68 to 3.99% for PCI.
Procedure use in hospitals that provide on-site CABG and PCI (Model 
3)
We observe a clear income gradient for invasive interven-
tions. For PCI, the adjusted rate is 19.9% for patients from
the poorest areas compared with 23.9% for patients from
richest areas, with a consistent positive correlation
between level of income and rate of treatment. For bypass
surgery, respective rates are 13 and 15.5%. Patients from
the poorest areas have a 47.8%-adjusted probability of
receiving no treatment at equipped hospitals versus
41.7% among patients from the richest areas. On the con-
trary, differences in adjusted probabilities remain quite
weak in magnitude, although significant, for CATH
(2.70% discrepancy between the lowest and the highest
adjusted rate).
To summarize, the highest rates of diagnosis and interven-
tion are found among patients from the richest areas.
However, as distances are included, differences across
income categories decline yet remain significant. Never-
theless, we observe a clear income gradient among
patients admitted to hospitals with on-site cardiac facili-
ties.
Quebec
Procedure use in all hospitals, unadjusted for distance (Model 1)
For all treatments, the highest adjusted rates are found
among patients from the richest areas followed by
patients in Q4- and Q1-areas. Like in the US, patients
from the poorest areas do not exhibit the lowest rates of
treatment. Nevertheless, adjusted probabilities do not sig-
nificantly differ in the case of CABG. The highest income
group exhibits the lowest rate of 'no treatment' (82.3%).
Procedure use in all hospitals, adjusted for distance (Model 2)
When controlling for distances, differences across income
categories become somewhat weak in magnitude for PCI:
the difference between extreme values decreases from 26
to 10%. However, for CATH, discrepancies remain high
Table 2: AMI population characteristics by income quintile 
(unadjusted)
INCOME QUINTILE
Q1 Q2 Q3 Q4 Q5
USA
% CATH 32.1 31.1 31.8 34.5 35.1
% PCI 12.0 11.3 11.6 12.7 13.1
% CABG 0.7 0.7 0.7 0.8 0.8
Average distance to CATH* 58.4 54.2 43.5 27.6 16.2
Average distance to REVASC* 45.2 48.0 37.4 21.1 13.2
% equipped hospitals 51.9 44.6 45.2 51.0 51.1
% total population 10.35 13.84 17.53 24.68 33.60
Quebec
% CATH 19.2 16.7 17.0 22.2 24.0
% PCI 6.7 5.6 5.9 7.0 7.6
% CABG 0.8 0.6 0.7 0.9 0.8
Average distance to REVASC* 55.5 80.8 88.6 41.7 24.7
% equipped hospitals 19.6 9.9 15.4 19.8 18.9
% total population 21.16 26.54 20.62 17.89 13.78
Belgium
% CATH 21.6 14.2 13.0 17.3 22.0
% PCI 5.8 3.4 3.0 5.1 7.2
% CABG 1.6 0.7 1.0 1.0 1.5
Average distance to CATH* 19.8 32.4 33.8 34.5 26.1
Average distance to REVASC* 13.4 14.4 14.7 15.1 11.3
% equipped hospitals 39.1 24.1 22.8 29.9 39.2
% total population 23.95 22.81 18.82 17.35 17.46
Note: *Average distance is expressed in kilometers (1 mile = 1.67 
km). Average distance to CATH measures the average distance to the 
nearest hospital with on-site facilities for CATH ONLY. Average 
distance to REVASC measures the average distance to the nearest 
hospital with on-site facilities to perform PCI or CABG.BMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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Table 3: Adjusted probabilities for income quintiles
USA CATH PCI CABG No treatment
Procedure use in all hospitals, unadjusted for distance (Model 1). N = 1,614,922
INC_Q1 0.1374* 0.1085* 0.0725* 0.6816
INC_Q2 0.1372* 0.1031* 0.0710* 0.6887
INC_Q3 0.1442* 0.1059* 0.0700* 0.6799
INC_Q4 0.1538* 0.1138* 0.0741* 0.6583
INC_Q5 0.1564* 0.1172* 0.0758* 0.6506
Range 13.99% 13.68% 8.29% 5.86%
Procedure use in all hospitals, adjusted for distance (Model 2). N = 1,614,992
INC_Q1 0.1600* 0.1168* 0.0766* 0.6466
INC_Q2 0.1573* 0.1149* 0.0766* 0.6512
INC_Q3 0.1584* 0.1127* 0.0730* 0.6559
INC_Q4 0.1592* 0.1149* 0.0747* 0.6512
INC_Q5 0.1564* 0.1172* 0.0756* 0.6508
Range 1.72% 3.99% 4.93% 1.44%
Procedure use in hospitals that provide on-site CABG and PCI (Model 3). N = 782,715
INC_Q1 0.1932* 0.1987* 0.1299* 0.4782
INC_Q2 0.1924* 0.2125* 0.1422* 0.4529
INC_Q3 0.1940* 0.2244* 0.1458* 0.4358
INC_Q4 0.1900* 0.2292* 0.1496* 0.4312
INC_Q5 0.1889* 0.2395* 0.1549* 0.4167
Range 2.70% 20.53% 19.25% 14.76%
QUEBEC CTH PCI CABG No treatment
Procedure use in all hospitals, unadjusted for distance (Model 1). N = 37,190
INC_Q1 0.0899* 0.0533* 0.0076 0.8492
INC_Q2 0.0834* 0.0474* 0.0061 0.8631
INC_Q3 0.0753* 0.0458* 0.0066 0.8723
INC_Q4 0.0980* 0.0521* 0.0074 0.8425
INC_Q5 0.1113* 0.0578* 0.0077 0.8232
Range 47.81% 26.20% 26.23% 5.96%
Procedure use in all hospitals, adjusted for distance (Model 2). N = 37,190
INC_Q1 0.0964* 0.0571* 0.0085 0.8380
INC_Q2 0.0925* 0.0538* 0.0077 0.8460
INC_Q3 0.0838* 0.0525* 0.0080 0.8557
INC_Q4 0.1011* 0.0550* 0.0078 0.8361
INC_Q5 0.1113* 0.0578* 0.0077 0.8232
Range 32.82% 10.10% 10.39% 3.95%
Procedure use in hospitals that provide on-site CABG and PCI (Model 3). N = 5,859
INC_Q1 0.1312 0.1448 0.0396 0.6844
INC_Q2 0.1274 0.1434 0.0446 0.6846
INC_Q3 0.1322 0.1302 0.0283 0.7093
INC_Q4 0.1462 0.1333 0.0390 0.6815
INC_Q5 0.1367 0.1562 0.0338 0.6733
range 14.76% 19.97% 57.60% 5.35%
BELGIUM CATH PCI CABG No treatment
Procedure use in all hospitals, unadjusted for distance (Model 1). N = 49,445
INC_Q1 0.1261* 0.0383* 0.0111* 0.8245
INC_Q2 0.0942* 0.0255* 0.0061* 0.8742
INC_Q3 0.0836* 0.0227* 0.0082* 0.8855
INC_Q4 0.0998* 0.0346* 0.0078* 0.8578
INC_Q5 0.1191* 0.0458* 0.0115* 0.8236
range 26.35% 101.76% 88.52% 7.40%
Procedure use in all hospitals, adjusted for distance (Model 2). N = 49,445
INC_Q1 0.1153* 0.0363* 0.0100* 0.8384
INC_Q2 0.1090* 0.0281* 0.0073* 0.8556
INC_Q3 0.0992* 0.0260* 0.0099* 0.8649
INC_Q4 0.1202* 0.0405* 0.0097* 0.8296BMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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between extreme categories of SES (32%). Differences
remain non-significant for CABG. For CATH and PCI, the
distribution remains similar, i.e., we observe a J-shaped
curve with the highest rates among patients from the rich-
est areas followed by those from the poorest ones.
In the 'no treatment' case, patients from richest areas still
exhibit the lowest adjusted rates. This outcome confirms
that the higher adjusted rate for CATH among extreme cat-
egories is the sign of a 'better' treatment. Indeed, higher
rates in the category 'CATH only' could be interpreted as a
less intensive treatment, that is, a diagnosis that is not fol-
lowed by an invasive procedure. This is not the case.
Procedure use in hospitals that provide on-site CABG and PCI (Model 
3)
Income plays no role among patients admitted to hospi-
tals with on-site cardiac facilities: adjusted rates do not sig-
nificantly vary across income groups.
Belgium
Procedure use in all hospitals, unadjusted for distance (Model 1)
In Belgium, for the three interventions, the highest
adjusted rates are found among patients who come from
'extreme' areas, i.e. poorest and richest areas (Q1 and Q5).
Adjusted PCI rates are 3.83% for patients from the poorest
areas, then decrease to 2.55 and 2.27% for patients in the
second and third quintile and increase again to 3.46 and
4.58% for the third and fourth quintile.
When we consider patients who did not receive treat-
ments (last column), the lowest adjusted rates are found
among patients from the poorest and richest areas (82.45
and 82.36% respectively).
Procedure use in all hospitals, adjusted for distance (Model 2)
When distances are included, we observe a J-shaped curve
for the three interventions. Distance plays a minor role in
Belgium, since distances to equipped hospitals differ on
average by only 3.81 km between the richest and poorest
areas.
Procedure use in hospitals that provide on-site CABG and PCI (Model 
3)
The highest rate of treatment among patients from the
richest area exists only in the case of PCI. The inverse J-
shaped curve remains for the 'no-treatment' case, with
higher rates among patients from the third quintile
(59.41%), and lowest among patients from the poorest
and richest areas (56.66 and 54.10% respectively). Even
when access to hospitals with on-site cardiac facilities is
fully insured, inequality remains across income catego-
ries.
Discussion
Our findings show that in all countries, the highest
adjusted treatment rates are found among patients from
the highest income areas, when not accounting for distances
between patient and hospital. This is true however to a lesser
extent in Quebec. In the US, distances from hospitals with
on-site catheterization and revascularization facilities are
shorter for richer areas. As a result, patients from those
areas have greater use of high-technology interventions
such as PCI or cardiac surgery.
When distances are accounted for, inequality becomes quite
low in the US, and is also reduced in Quebec. That is, if the
issue of distance is controlled for, all three health care sys-
tems achieve low levels of inequality in use of high-tech-
nology interventions. Thus, it appears that income
inequality is largely related to location of hospitals with
catheterization and revascularization capabilities, particu-
larly in the US.
In the US, the richer the area, the closer the cardiac serv-
ices. By contrast, greatest distances are observed in Bel-
gium and Quebec among middle-income areas. It is thus
not surprising to observe a more pronounced income gra-
dient in the US that almost disappears when controlling
for distances to equipped facilities. Hence, the main cause
of income inequality does not seem to be income itself
but instead distances from equipped hospitals. These
findings substantiate those of previous studies showing
INC_Q5 0.1191* 0.0458* 0.0115* 0.8236
range 21.17% 76.15% 57.53% 5.01%
Procedure use in hospitals that provide on-site CABG and PCI (Model 3). N = 14,952
INC_Q1 0.2669* 0.1293* 0.0372* 0.5666
INC_Q2 0.2633* 0.1127* 0.0299* 0.5941
INC_Q3 0.2753* 0.1042* 0.0419* 0.5786
INC_Q4 0.2853* 0.1329* 0.0331* 0.5487
INC_Q5 0.2701* 0.1511* 0.0378* 0.5410
Range 8.36% 45.01% 40.13% 9.81%
Notes: estimates for SES variables obtained from multinomial logit regression (adjusted probabilities are adjusted for age groups, year and 
comorbidities). This Table should be read as follows: e.g., for individuals from the US living in the lowest quintile (Q1) income area, the adjusted 
probability of undergoing a CATH is 0.1374, controlling for age, sex, comorbidities and year. The 'no treatment' category is obtained by simple 
subtraction; hence it does not include any indication about statistical significance.
*Estimate significantly differs from at least one other quintile's estimate at p ≤ 0.05.
Table 3: Adjusted probabilities for income quintiles (Continued)BMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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the impact of geographic proximity of revascularization
services on service utilization [15,17].
The question however remains about why income and
distance to equipped hospitals are strongly related in the
US while this is not the case in Belgium and Quebec. The
first straightforward explanation is that the poorest areas
in the US are also the least populated (rural areas), in con-
trast with Belgium and Quebec.
However, this double disadvantage of poverty and non-
urban setting may also be related to organizational char-
acteristics. In particular, high-technology procedures are
costly in terms of equipment and human capital [12];
when hospitals are free to keep their profits and invest
according to their own interests, investments will concen-
trate among hospitals with more financial capacity or
with greater expected profitability of treatments. Poor or
inadequate regulation of investments may thus explain
the above findings. Consider the US, in which invest-
ments in technology are generally not regulated. In
densely populated urban areas, demand for cardiac proce-
dures is high. As a result, large hospitals use their profits
to invest in medical equipment that give their patients
access to high technology treatments [18]. However, rural
areas in the US, which are poorer than urban areas, do not
have the money to invest and thus patients must seek car-
diac treatments from facilities located far away, generally
in the nearest city.
Furthermore, insurance may also play a role. Studies have
shown that hospital's investments in the US are driven by
expected financial returns, which depend upon payer type
[16]. Fee-for-service (FFS) commercial payers provide the
greatest average returns, followed by Medicare, HMOs and
Medicaid. Meanwhile, patient's insurance type and
income are known to be related (FFS is more prevalent in
high-income areas, e.g. [4]). Hence, hospitals in richer
areas are more likely to invest in costly new techniques
because their profitability is guaranteed by the higher pay-
ments of their patients' insurance schemes. Thus Medicare
patients from richer and urban areas may benefit from
greater use of high-technology procedures due to their
location closer to hospitals with on-site cardiac facilities.
Among  patients admitted to hospitals with on-site cardiac
facilities, we get a classical social gradient in the US, and
still some inequality in favor of the better-off in Belgium
in the case of PCI. This is surprising since Belgium and US
Medicare are characterized by a generous universal cover-
age and distances to cardiac services are less relevant at
this stage. A myriad of causes may explain this finding,
and our study was not designed to address them. Potential
explanations include the differences in patients' willing-
ness to undergo invasive interventions, physician preju-
dices, and unobserved differences in severity of disease
[4,6,8-10].
Special emphasis should however be given to Quebec,
which does not exhibit significant inequality within this
sub-sample, contrary to Belgium and the US. It is hardly
plausible that the causes mentioned already do not apply
to Quebec, since universal coverage is common to the
three systems. Organizational factors may once again be
at play. In particular, Medicare patients in the US may be
insured through HMOs or FFS, leading to different use of
cardiac services [19]. In Belgium, anecdotal evidence sug-
gests that patients with supplementary private insurance
may receive a higher-quality treatment due to their higher
profitability for the hospital. The greater homogeneity of
the insurance system in Quebec may prevent income-
related inequality to occur among patients treated at fully
equipped hospitals. A study including a larger number of
countries with different health care system could test these
assumptions.
Study limitations
Our results are obtained using area-based SES variables.
Geronimus and Bound [20] have measured that, using
area-based variables instead of individual-level ones, the
impact of SES on health is likely to be underestimated due
to area's socio-economic heterogeneity. For example
richer patients, who can afford costly treatments, will be
attributed to the low median income of their living area,
resulting in underestimation of results. Areas in the US
have an average population of 8,440, compared to 17,170
in Belgium and 19,037 in Quebec. Hence, heterogeneity is
likely to be higher in Belgium and Quebec, partly explain-
ing the lower impact of SES in these countries. However,
other authors suggest that people's health care use is
affected by area factors, regardless of the individual
SES[21]; this may counteract the expected underestima-
tion of the SES impact.
Note also that the areas' heterogeneity in distances may
differ between countries. Belgian areas are too small to
exhibit strong heterogeneity in distances and the Forward
Sortation Areas in Quebec are either urban or rural. By
contrast, US census tracks, although they are designed to
produce homogenous populations, have varying land
area depending on the population density. Considering
that the patient lives in his area's geographical center is a
limitation which likely leads to underestimate the impact
of distance in the US. Note that, despite this limitation,
distances are shown to be a crucial determinant in our
study.
Also, the use of administrative data does not include as
detailed clinical information on severity of illness as a
detailed survey would. Hannan et al. [22] show thatBMC Health Services Research 2009, 9:130 http://www.biomedcentral.com/1472-6963/9/130
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administrative data fails to distinguish co-morbidities and
complications, and does not contain information on pre-
vious open-heart surgery, nor on ejection fraction. How-
ever, administrative data generally have the advantage of
including more patients and representing a wider geo-
graphical area.
Finally, our sample for the US is restricted to Medicare
patients, while data for Belgium and Quebec include all
patients older than 65. One may argue, however, that the
non-Medicare patients are marginal among the elderly
(5% people). In addition, the income distribution in the
US is more unequal than in Belgium and Quebec (accord-
ing to the World Bank development indicators [23], the
Gini index was 40.8 in the US, 32.6 and 33.0 in Canada
and Belgium respectively). Hence, US Medicare patients
may be more homogenous than the whole US popula-
tion, but not more homogenous than the Belgian or Que-
bec samples. Meanwhile, restricting our sample to
Medicare patients enables a comparison of health care
schemes that only differ in easily identifiable peripheral
characteristics. This facilitates interpretation of results and
comparisons across countries.
Conclusion
Our outcomes first clearly indicate that income-related
inequality does exist in use of high-technology treatment,
and that this inequality is not explained by differences in
the patients' health condition. This confirms results from
previous literature. Inequality is largely explained, in the
US and Quebec, by location of care. When distances are
accounted for, inequality substantially decreases in mag-
nitude. However, in both Belgium and the US, inequali-
ties persist among patients admitted to hospitals with on-
site cardiac facilities, rejecting the hospital location effect
as the only explanation for inequalities.
Secondly, inequality differs across countries. As stated
above, some features of hospital financing may exacerbate
income-related inequalities in treatment, such as insur-
ance type and investment regulations. Due to the diver-
gence of these features between countries, we have good
reason to believe they are affecting the diagnosis and treat-
ment of AMI patients. Those assumptions should be
tested using a larger set of countries making available a
larger array of health care systems.
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